findmyKOL

Michael Hoskins, MD

Basic profile

New Mexico Heart Institute

ORCIDNone on fileNPI
RegionAlbuquerque, NM · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Hoskins is a Cardiology physician affiliated with New Mexico Heart Institute. OpenAlex indexes 87 publications with 999 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
87publications

Distinct works indexed by OpenAlex.

999citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
31companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

502 Elm St NE
Albuquerque, NM 87102

Telephone

505-841-1000

Provider last certified this registry record 20 Mar 2025.

View the NPPES registry record

Industry payments

31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    59.8%
    Beta blocker21.3%
    Metoprolol Succinate39%Carvedilol30%Metoprolol Tartrate25%Sotalol6%
    Part D55 patients
    Antiarrhythmic13.6%
    Flecainide Acetate90%Dofetilide11%
    Part D<11 patients

    + 8 more classes in this area

  • Blood & clotting

    39.1%
    Factor Xa inhibitor33.5%
    Eliquis89%Xarelto11%
    Part D143 patients
    P2Y12 inhibitor5.6%
    Clopidogrel100%
    Part D67 patients
  • Metabolism & gastrointestinal

    1.1%
    Potassium supplement1.1%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)99.6% facility · 0.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”